Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study
Research output: Contribution to journal › Journal article › Research › peer-review
This study aimed to investigate whether CYP3A4/5 genetic variants, together with clinical and patient factors, influence serum fentanyl and norfentanyl concentrations and their ratio in cancer pain patients receiving transdermal fentanyl.
| Original language | English |
|---|---|
| Journal | Pharmacogenetics and Genomics |
| Volume | 24 |
| Issue number | 4 |
| Pages (from-to) | 185-194 |
| Number of pages | 10 |
| ISSN | 1744-6872 |
| Publication status | Published - 2014 |
Links
ID: 101829242